Welcome to Our Blog
Check back each month for blog posts from innovaTel Telepsychiatry pertaining to mental health, telepsychiatry, regulations, and company updates.
In the medical field, clinician turnover can take its toll on organizations, patients, and the clinicians themselves. Clinician turnover can be especially difficult in the
Written by Dr. Mia McNeil, Director of Clinical Nurse Practitioner Services The COVID-19 pandemic has challenged our healthcare infrastructure in many ways. It also challenged
With the rising demand for behavioral health services, especially in the current climate where social distancing is a daily requirement; getting patients seen in a
Historically, tele-behavioral health implementations require thoughtful planning to develop protocols and robust provider training to ensure successful implementations. Due to COVID-19, organizations are rolling out
After another busy year, I’d like to take a moment to reflect on what innovaTel Telepsychiatry accomplished in its fifth year of business and where
While the efficacy of telepsychiatry as a method of delivering psychiatric care has been extensively researched and tested, what has not been examined in as
At innovaTel, we understand the importance of fostering a work environment that our employees and clinicians can thrive in. Working in the behavioral health field
October is National Depression and Mental Health Screening Month. This month we reflect on the importance of early intervention and the positive effect it can
With the behavioral health workforce shortage, community mental health centers often experience the challenge of not having a large enough team to meet the high
September is National Suicide Prevention Awareness Month, a time to share resources and have conversations in an effort to shed light on this stigmatized topic.
National Health Center Week: The Positive Impact innovaTel Partners Have on Their Communities August 11th-17th is National Health Center Week. The goal of National Health
A lively discussion took place this morning regarding the anticipated Drug Enforcement Administration (DEA) Special Registration Rule for the prescribing of controlled substances via telemedicine.